Gianluca Sala

2.8k total citations
64 papers, 1.9k citations indexed

About

Gianluca Sala is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gianluca Sala has authored 64 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 35 papers in Molecular Biology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gianluca Sala's work include HER2/EGFR in Cancer Research (21 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Gianluca Sala is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Gianluca Sala collaborates with scholars based in Italy, United Kingdom and Australia. Gianluca Sala's co-authors include Stefano Iacobelli, Emily Capone, Vincenzo De Laurenzi, Marco Falasca, Rossano Lattanzio, Oreste Segatto, Tania Maffucci, Mauro Piantelli, Cosmo Rossi and Stefano Alemà and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gianluca Sala

60 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianluca Sala Italy 24 1.1k 761 336 240 225 64 1.9k
Christine Tan United States 10 1.2k 1.1× 487 0.6× 272 0.8× 318 1.3× 243 1.1× 17 1.9k
Azucena Esparís‐Ogando Spain 27 1.3k 1.2× 861 1.1× 310 0.9× 171 0.7× 262 1.2× 45 2.0k
Antonella Zannetti Italy 27 1.1k 1.0× 669 0.9× 278 0.8× 240 1.0× 426 1.9× 66 2.0k
Maria Sundvall Finland 20 1.2k 1.1× 949 1.2× 364 1.1× 97 0.4× 289 1.3× 33 1.8k
Andreas Gschwind Germany 9 1.6k 1.5× 1.1k 1.5× 383 1.1× 212 0.9× 311 1.4× 10 2.7k
Landon J. Inge United States 21 1.1k 1.0× 433 0.6× 175 0.5× 115 0.5× 307 1.4× 41 1.7k
Matthew V. Lorenzi United States 28 1.5k 1.3× 920 1.2× 179 0.5× 421 1.8× 367 1.6× 64 2.6k
Karen Rex United States 17 696 0.6× 476 0.6× 191 0.6× 137 0.6× 119 0.5× 32 1.6k
Andreas Menrad Germany 20 682 0.6× 513 0.7× 280 0.8× 267 1.1× 206 0.9× 30 1.5k
Angera H. Kuo United States 18 1.6k 1.4× 902 1.2× 186 0.6× 464 1.9× 565 2.5× 23 2.6k

Countries citing papers authored by Gianluca Sala

Since Specialization
Citations

This map shows the geographic impact of Gianluca Sala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Sala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Sala more than expected).

Fields of papers citing papers by Gianluca Sala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Sala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Sala. The network helps show where Gianluca Sala may publish in the future.

Co-authorship network of co-authors of Gianluca Sala

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Sala. A scholar is included among the top collaborators of Gianluca Sala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Sala. Gianluca Sala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pellegrino, Raffaello, David Perpetuini, Roberto Paganelli, et al.. (2025). Galectin-3-binding protein is a risk factor for diabetes, metabolic syndrome, and inflammation. Cross-sectional and longitudinal results from the InCHIANTI study. Mechanisms of Ageing and Development. 226. 112086–112086.
2.
Giacomo, Viviana di, Maria Carmela Di Marcantonio, Tirtha Raj Acharya, et al.. (2024). Cold atmospheric plasma activated media selectively affects human head and neck cancer cell lines. Oral Diseases. 31(2). 401–416. 5 indexed citations
3.
Fracasso, Giulio, Elisabetta Falvo, Gianluca Sala, et al.. (2023). Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers. Heliyon. 9(10). e20770–e20770. 4 indexed citations
4.
Capone, Emily, Beatrice Dufrusine, Francesco Pizzo, et al.. (2023). HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target. Cell Death Discovery. 9(1). 400–400. 5 indexed citations
5.
Caponio, Vito Carlo Alberto, Emily Capone, Marco Mascitti, et al.. (2023). LGALS3BP is a potential target of antibody‐drug conjugates in oral squamous cell carcinoma. Oral Diseases. 30(4). 2039–2050. 5 indexed citations
6.
Keinänen, Outi, Emily Capone, Rodolfo Ippoliti, et al.. (2023). Visualizing Galectin-3 Binding Protein Expression with ImmunoPET. Molecular Pharmaceutics. 20(6). 3241–3248. 5 indexed citations
7.
Lattanzio, Rossano, Gianluca Sala, Melissa Millard, et al.. (2023). The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS Letters. 598(2). 252–265. 6 indexed citations
8.
Carregari, Victor Corasolla, Martina Morini, Alessandra Eva, et al.. (2021). MYC regulates metabolism through vesicular transfer of glycolytic kinases. Open Biology. 11(12). 210276–210276. 9 indexed citations
9.
Dufrusine, Beatrice, Emily Capone, Damiana Pieragostino, et al.. (2021). BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration. Journal of Cellular Biochemistry. 123(1). 65–76. 12 indexed citations
10.
Capone, Emily, Stefano Iacobelli, & Gianluca Sala. (2021). Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target. Journal of Translational Medicine. 19(1). 405–405. 89 indexed citations
11.
Capone, Emily, Rossano Lattanzio, Fabio Gasparri, et al.. (2021). EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors. Pharmaceutics. 13(4). 483–483. 15 indexed citations
12.
Perrotti, Vittoria, Vito Carlo Alberto Caponio, Marco Mascitti, et al.. (2021). Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review. Cancers. 13(13). 3126–3126. 17 indexed citations
13.
Lamolinara, Alessia, Emily Capone, Stefania Purgato, et al.. (2020). Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac. Oncogenesis. 9(1). 3–3. 8 indexed citations
14.
D’Agostino, Daniela, Roberta Gentile, Francesco Dituri, et al.. (2020). EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer. Oncology Reports. 45(2). 776–785. 11 indexed citations
15.
Falvo, Elisabetta, Alessandro Arcovito, Giamaica Conti, et al.. (2020). Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy. Pharmaceutics. 12(10). 992–992. 17 indexed citations
16.
Pitari, Giuseppina, Annamaria Cimini, Matteo Ardini, et al.. (2020). Antibody-Drug Conjugates: The New Frontier of Chemotherapy. International Journal of Molecular Sciences. 21(15). 5510–5510. 125 indexed citations
17.
Casari, Ilaria, Alice Domenichini, Simona Sestito, et al.. (2019). Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation. Cancers. 11(11). 1695–1695. 8 indexed citations
18.
Giansanti, Francesco, Emily Capone, Enza Piccolo, et al.. (2018). Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates. Journal of Controlled Release. 294. 176–184. 32 indexed citations
19.
Capone, Emily, Alessia Lamolinara, Daniela D’Agostino, et al.. (2018). EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma. Journal of Controlled Release. 277. 48–56. 28 indexed citations
20.
Sala, Gianluca, Francesco Dituri, Claudio Raimondi, et al.. (2008). Phospholipase Cγ1 Is Required for Metastasis Development and Progression. Cancer Research. 68(24). 10187–10196. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Tan Breakdown of academic impact, for papers by Azucena Esparís‐Ogando Breakdown of academic impact, for papers by Antonella Zannetti Breakdown of academic impact, for papers by Maria Sundvall Breakdown of academic impact, for papers by Andreas Gschwind Breakdown of academic impact, for papers by Landon J. Inge Breakdown of academic impact, for papers by Matthew V. Lorenzi Breakdown of academic impact, for papers by Karen Rex Breakdown of academic impact, for papers by Andreas Menrad Breakdown of academic impact, for papers by Angera H. Kuo
Rankless by CCL
2026